The novel predictor of metabolic risk in patients with polycystic ovary syndrome: could it be the visceral adiposity index?

European review for medical and pharmacological sciences(2022)

Cited 1|Views7
No score
Abstract
After comparing data in groups with similar BMI levels, we found significantly high VAI values in patients with PCOS. The results reinforce the idea that VAI is a useful marker easily obtained in daily practice for assessing the cardiometabolic risk of patients with PCOS.
More
Translated text
Key words
Cardiometabolic risk, Insulin resistance, Polycystic ovary syndrome, VAI
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined